Cutaneous reactions post‐COVID‐19 vaccination. Case series and literature review

Abstract Background In Saudi Arabia, three approved vaccines against severe acute respiratory syndrome coronavirus 2 (AstraZeneca [AZD1222], Pfizer‐BioNTech [BNT162b2] and [Ad26. COV 2‐S] Moderna vaccine) have been administered to the population. Objective To characterise cutaneous adverse events as...

Full description

Bibliographic Details
Main Authors: Fatimah J. Al‐Muqarrab, Omar M. Alakloby, Mohammed A. Al Ameer, Abdulmohsen M. Alhajri
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:JEADV Clinical Practice
Subjects:
Online Access:https://doi.org/10.1002/jvc2.56